Hamilelikte sodium hydroxymethylglycinate kullanmaktan kaçınmalı mıyım? | VeriMom
No harmonised reproductive classification (H360/H361) is listed for sodium N-(hydroxymethyl)glycinate; the legally binding ECHA Annex VI classifications provided are for carcinogenicity/mutagenicity and acute hazards related to formaldehyde release, not for reproductive toxicity. There are no authoritative (CIR/SCCS/harmonised) indications of reproductive/developmental toxicity for this ingredient, but topical use can result in low measurable exposure (preservative/formaldehyde releaser).
ECHA regulatory hazard statements
- •H350
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- sodium hydroxymethylglycinate hamilelikte güvenli mi?
- No harmonised reproductive classification (H360/H361) is listed for sodium N-(hydroxymethyl)glycinate; the legally binding ECHA Annex VI classifications provided are for carcinogenicity/mutagenicity and acute hazards related to formaldehyde release, not for reproductive toxicity. There are no authoritative (CIR/SCCS/harmonised) indications of reproductive/developmental toxicity for this ingredient, but topical use can result in low measurable exposure (preservative/formaldehyde releaser).
- sodium hydroxymethylglycinate emzirirken güvenli mi?
- No evidence or harmonised classification indicating reproductive or lactation-specific toxicity; mechanism of reproductive harm is not established. Dermal cosmetic exposure would give low but potentially measurable systemic exposure to parent compound/formaldehyde, so a low exposure concern during breastfeeding is prudent, though no specific data indicate transfer into breast milk for this ingredient.
- sodium hydroxymethylglycinate bebek cildi için güvenli mi?
- No infant-specific reproductive hazards documented. However, owing to infants' higher skin permeability and surface-area-to-weight ratio, exposure scoring is increased by +1 relative to adults (adult e=1 → infant e=2). Additionally, as a formaldehyde releaser, it can cause irritation or sensitisation which is relevant for infant skin, though reproductive-specific effects in infants are not reported.
- VeriMom sodium hydroxymethylglycinate nasıl puanlıyor?
- VeriMom sodium hydroxymethylglycinate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 33/100 (yüksek risk) olarak puanlar.
- Hamilelikte sodium hydroxymethylglycinate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.